Answers are grounded in this paper and cite their sources.
Graves' ophthalmopathy is one of most frequent extrathyroid manifestation of autoimmune thyroid diseases. In 3–5% cases it has severe progress and requires specific therapy. There are many methods of treatment and it's getting more and more, but that demonstrate no sufficient effectiveness. In this review was made an essay to systematize current data. Also guidelines of consensus EUGOGO for treatment of ophtalmopathy is represented here.
No takes yet. Share an insight, caveat, or question.
Dalmatova et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: